Loading...
Patient Advocacy2018-10-05T23:32:41+00:00

In the News

What’s the latest in the news regarding Kidney Cancer? Keep up to date right here!


Our Communities

Smart Patients is an online community where patients and their families learn from each other. Patients can be extraordinarily knowledgeable about their disease. Get information and support from patients who have expertise to share with you.

TO CONNECT TO HUNDREDS OF OTHER KIDNEY CANCER PATIENTS:

October 2, 2018

Nobel Prize Winner 2018 – Immunotherapies

James P. Allison, Ph.D., director of the Cancer Research Institute Scientific Advisory Council, has been awarded the 2018 Nobel Prize in...
Read More
August 8, 2018 / Front News, News Page

Columnist Robert Wilonsky Speaks About His Battle With Cancer

NBC Today Anchor Marc Fein: I had the honor of talking to DMN Dallas City Columnist Robert Wilonsky today about his battle with cancer. He was told he wouldn’t see his son’s next birthday. He did, and his story is remarkable.
Read More
August 6, 2018 / Front News, News Page

Late-stage kidney cancer should have killed me. Thanks to these Dallas doctors, I have a chance

Robert Wilonsky, City Columnist Last summer, my doctor told me I would probably be dead before my son went to...
Read More
July 21, 2018

New Clinical Trial at NIH

Researchers at the National Institutes of Health (NIH) in Bethesda, Maryland, are enrolling patients with kidney cancer (renal cell carcinoma) into a gene therapy study– a new type of precision medicine that genetically reprograms your immune cells to specifically recognize and kill tumor cells.
Read More
July 16, 2018 / News Page

Newly diagnosed metastatic renal cell carcinoma

Daniel George, MD; Toni Choueiri, MD; Walter Stadler, MD; and Richard W. Joseph, MD, discuss data from the CABOSUN trial and the expanded FDA approval for cabozantinib versus sunitinib for previously untreated patients with advanced renal cell carcinoma.
Read More
July 16, 2018 / News Page

Cancer patient saved by ‘seek and destroy’ cells

The first NHS cancer patient to benefit from a breakthrough procedure that primes the body’s immune system to ‘seek and destroy’ tumour cells has stunned doctors with his recovery after being given just weeks to live.
Read More
July 5, 2018 / News Page

American Cancer Society Current Grants

American Cancer Society Current Grants by Cancer Type Current as of March 1, 2018 Cancer Type Number of Grants involving...
Read More
July 3, 2018 / News Page

Dr Choueiri discusses checkpoint inhibitors in RCC

CLICK HERE TO VIEW THE VIDEO
Read More
June 28, 2018 / News Page

The PIVOT-02 Trial: NKTR-214 With Nivolumab

Adi Diab, MD, discusses the synergistic mechanisms of NKTR-214 and nivolumab and the promising results of the phase I/II PIVOT-02 trial evaluating the use of NKTR-214 combined with nivolumab in multiple solid tumor types.
Read More
June 26, 2018 / News Page

Heading Toward Personalized Management of Advanced Kidney Cancer

The heterogeneity of kidney cancer makes each of the tumors unique and treatment decisions based on tumor characteristics especially challenging.
Read More
June 26, 2018 / News Page

Dr. Pal Discusses the Role of PD-L1 in Metastatic RCC

Sumanta Kumar Pal, MD, associate clinical professor, Department of Medical Oncology and Therapeutics Research, co-director, Kidney Cancer Program, City of Hope, discusses the role of PD-L1 in metastatic renal cell carcinoma (RCC).
Read More
June 25, 2018 / News Page

Pembrolizumab active as first-line therapy in renal cell carcinoma subtype

Pembrolizumab monotherapy in the first-line setting induced a response among nearly 40% of patients with clear cell renal cell carcinoma across all IMDC risk groups, according to interim results from cohort A of the KEYNOTE-427 trial presented at the ASCO Annual Meeting.
Read More
June 22, 2018 / News Page

Investigating Immunotherapy Treatment in Renal Cell Carcinoma

Charles G. Drake, MD, PhD, professor of medical oncology at New York Presbyterian/Columbia University Medical Center, discusses his thoughts on whether sunitinib would be more successful as a treatment for patients with renal cell carcinoma if used in the neoadjuvant setting. He debates whether immunotherapies or neoadjuvant therapies would be more useful.
Read More
June 20, 2018 / News Page

The Rapidly Evolving Landscape of Immunotherapy 6/20/2018

CLICK HERE TO READ THE FULL ARTICLE
Read More
September 12, 2017 / News Page

Combination immunotherapy FDA approved

Combination immunotherapy improves kidney cancer survival September 12, 2017| Media Contact: Avery Anderson Dr. Hans Hammers, Associate Professor of Internal Medicine and...
Read More
August 21, 2017 / Front News, News Page

Immunotherapy Trial – Patient Success Story

72-year-old Larry Carlson was diagnosed with stage IV CCRCC in November of 2014. He came to the UT Southwestern Kidney Cancer Program shortly after. Larry shares his journey through diagnosis, surgery, and immunotherapy.
Read More
March 7, 2017 / News Page

First Ever Kidney Cancer Funding from Congress (CDMRP)

Congressionally-directed Medical Research Program. It took over a decade of hard work from kidney cancer advocates to obtain kidney cancer-specific research funding included in the federal budget. Nevertheless, in March of 2017 Congress approved and the president signed the Consolidation Appropriations Act.
Read More
November 10, 2016 / News Page

UT Southwestern – Cutting-edge Discoveries, Transforming Patient Care

UT Southwestern - Cutting-edge Discoveries, Transforming Patient Care The American Cancer Society estimates that in 2014, 63,920 people were diagnosed...
Read More
September 10, 2016 / News Page

New HIF-2 kidney cancer therapy more effective than current treatment, study shows

UT Southwestern investigators report in Nature a new class of drugs against renal cancer, HIF-2 inhibitors, which are more efficacious...
Read More